Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium-glucose Cotransporter 2”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Testing effectiveness (Phase 2)Looking for participantsNCT07245069
What this trial is testing

Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Who this might be right for
Heart FailureAnthracycline-induced Cardiac ToxicityEndothelial Function (FMD)+2 more
University Medical Centre Ljubljana 100
Post-approval studies (Phase 4)Looking for participantsNCT05672836
What this trial is testing

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Who this might be right for
Aortic Valve StenosisHeart Failure
Duk-Woo Park, MD 1,040
Post-approval studies (Phase 4)Study completedNCT06026787
What this trial is testing

Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeSodium-Glucose Transporter 2 Inhibitors
Ain Shams University 60
Post-approval studies (Phase 4)Study completedNCT06383832
What this trial is testing

Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet.

Who this might be right for
OverweightCarbohydrateSodium-glucose Transporter 2 Inhibitors
Sun Jia 36
Large-scale testing (Phase 3)Study completedNCT04304261
What this trial is testing

Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

Who this might be right for
Diabetes Mellitus, Type 2Cognitive Functions Confusion
Third Military Medical University 100
Not applicableStudy completedNCT05417646
What this trial is testing

Impact of SGLT2 on Glucosuria in HNF1A-MODY

Who this might be right for
Maturity-Onset Diabetes of the Young, Type 3Type 2 Diabetes
Steno Diabetes Center Copenhagen 21
Not applicableStudy completedNCT06964607
What this trial is testing

Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

Who this might be right for
Sodium-glucose Cotransporter 2InhibitorsClinical Outcome+2 more
Tanta University 80
Early research (Phase 1)Study completedNCT06828731
What this trial is testing

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

Who this might be right for
Prediabetes
Charles George VA Medical Center 60
Not applicableStudy completedNCT05890131
What this trial is testing

Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy

Who this might be right for
Heart Failure
Morten Schou 5,996
Not applicableStudy completedNCT06903754
What this trial is testing

ISGLT2 in Patients Without DM With Acute MI

Who this might be right for
Acute Coronary SyndromesHeart Failure
Mohammed VI University Hospital 450
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableLooking for participantsNCT07444203
What this trial is testing

Transformative Research in Diabetic Nephropathy 2.0

Who this might be right for
Diabetic NephropathiesKidney DiseasesRenal Insufficiency, Chronic+1 more
University of Pennsylvania 200
Post-approval studies (Phase 4)Study completedNCT04461041
What this trial is testing

Empagliflozin and Cardiac Remodelling in People Without Diabetes

Who this might be right for
Cardiovascular DiseasesLeft Ventricular Hypertrophy
Unity Health Toronto 169
Post-approval studies (Phase 4)Study completedNCT02700334
What this trial is testing

Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes

Who this might be right for
PrediabetesImpaired Fasting GlucoseImpaired Glucose Tolerance
University of Guadalajara 24
Post-approval studies (Phase 4)Study completedNCT01939496
What this trial is testing

Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents

Who this might be right for
Diabetes Mellitus, Type 2Hypertension
Janssen Scientific Affairs, LLC 171
Post-approval studies (Phase 4)UnknownNCT02577159
What this trial is testing

Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)

Who this might be right for
Diabetes Mellitus, Type 2
Osaka University 50
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Large-scale testing (Phase 3)Study completedNCT05676684
What this trial is testing

Dapagliflozin With or Without Spironolactone for HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Universidade do Porto 108
Testing effectiveness (Phase 2)Study completedNCT03316131
What this trial is testing

Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA

Who this might be right for
Asymptomatic Hyperuricemia
AstraZeneca 36
Load More Results